Yilmaz Kafali, Helin http://orcid.org/0000-0002-6009-1085
Solerdelcoll, Mireia
Vujinovic, Lena
Martsenkovskyi, Dmytro
Awhangansi, Sewanu
Noel, Camille
Bora, Emre
Arango, Celso
Article History
Received: 17 April 2021
Accepted: 13 October 2021
First Online: 20 October 2021
Declarations
:
: Dr. Solerdelcoll receives grant support from the Alicia Koplowitz Foundation. Dr Arango has been supported by the Spanish Ministry of Science and Innovation. Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024), co-financed by ERDF Funds from the EuropeanCommission, “A way of making Europe”, CIBERSAM. Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds. European Union Seventh Framework Program under grant agreements FP7-4-HEALTH-2009-2.2.1-2-241909 (Project EU-GEI), FP7- HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and FP7-HEALTH-2013-2.2.1-2-602478 (Project METSY); and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No 115916, Project PRISM, and grant agreement No 777394, Project AIMS-2-TRIALS), Fundación Familia Alonso and Fundación Alicia Koplowitz. The authors declare that they have no potential conflicts of interest in relation to this article.
: This study was approved by the clinical research ethics review committee of the Ministry of Health Ankara City Hospital from Ankara, Turkey (E1/090/2019, 24.10.2019).
: Only the survey administrator had access to the personally identifiable information of participants. Informed consent was acquired before each participant administered the questionnaire online.
: The Authors hereby consent to publication of the Work in European Child and Adolescent Psychiatry.